Science Explorer Interactive view Map
Company · Columbia · United States

Ark Therapeutic (United States)

arktherapeutic.comROR OpenAlex
Research works
71
▲ 63% vs 2013–17
Citations
4.8k
68.1 per fractional work
Top-10% rate
13.8%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Ark Therapeutic (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.66× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 17.24× its world share, 4 worksImmunology and Micro…Neuroscience: 1.50× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.51× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.80× its world share, 0 worksChemical EngineeringChemistry: 0.07× its world share, 0 worksChemistryEngineering: 0.26× its world share, 1 worksEngineeringMaterials Science: 0.25× its world share, 0 worksMaterials ScienceHealth Professions: 0.36× its world share, 0 worksHealth ProfessionsMedicine: 2.40× its world share, 11 worksMedicineEconomics, Econometrics and Finance: 0.85× its world share, 0 worksEconomics, Econometr…Psychology: 1.05× its world share, 1 worksPsychologySocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.2×. Every wedge is a field page.

Which keywords describe research at Ark Therapeutic (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Immunity, Cancer, Tumor Regression, Lymphoma, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Cancer Immunotherapy4▲ 111×3 topics
  2. Immunotherapy3▲ 20×6 topics
  3. Immunity3▲ 33×4 topics
  4. Cancer3▲ 9.1×11 topics
  5. Tumor Regression3▲ 103×2 topics
  6. Inflammation2▲ 5.0×9 topics
  7. CAR T Cells2▲ 124×1 topic
  8. Chimeric Antigen Receptor2▲ 124×1 topic
  9. Lymphoma2▲ 58×2 topics
  10. Metabolism2▲ 15×5 topics
  11. Gene Therapy2▲ 34×4 topics
  12. Innate Immunity2▲ 20×3 topics
  13. Tumor Microenvironment2▲ 15×4 topics
  14. Activation1▲ 101×1 topic
  15. Antigen Presentation1▲ 67×1 topic
  16. Dendritic Cells1▲ 65×1 topic
  17. Macrophage1▲ 83×1 topic
  18. Oxidative Stress1▲ 3.5×11 topics
  19. Cancer Therapy1▲ 8.0×7 topics

Which research topics does Ark Therapeutic (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune cells in cancer, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksImmune cells in cancer: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksVirus-based gene therapy research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCancer Research and Treatments: 0 fractional worksUltrasound and Hyperthermia Applications: 0 fractional worksPhagocytosis and Immune Regulation: 0 fractional worksCancer Cells and Metastasis: 0 fractional works
OncologyImmunologyGeneticsRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Immune cells in cancer Immunology 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Virus-based gene therapy research Genetics 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Cancer Research and Treatments Biotechnology 0 works
  8. 8 Ultrasound and Hyperthermia Applications Biomedical Engineering 0 works
  9. 9 Phagocytosis and Immune Regulation Immunology 0 works
  10. 10 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.8%not open51.2%

World: 28% of research is openly available.

with international co-authors39.7%domestic only60.3%

World: 19% is written across borders.

How has Ark Therapeutic (United States)'s research output changed?

Output in 2018–2022 was 63% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Columbia

All research institutions in Columbia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.